PuriCore Plc announces Appointment
13th Nov 2006, 19:52 GMT
...
PuriCore Plc announces Appointment related news:
- PuriCore Plc: PuriCore Plc announces Appointment — Market Wire - Environment
- SkyePharma PLC announces Board Appointment — ArriveNet : Press Releases
- SkyePharma PLC: SkyePharma PLC announces Board Appointment — Market Wire - Pharmaceuticals and Biotech
- McInerney announces new MD for Spanish operations — BreakingNews.ie - Business
- Acambis PLC: Acambis PLC announces Update on US MVA procurement — Market Wire - Pharmaceuticals and Biotech
- Scottish Power PLC: Scottish Power PLC announces ADS Dividend Declaration — Market Wire - Energy and Utilities
- Scottish Power PLC: Scottish Power PLC announces Interim Results — Market Wire - Energy and Utilities
- Modern Technology Corp Announces Significant Appointment to Insight Medical Group's Scientific Advisory Panel — ArriveNet : Business
- Scottish Power PLC announces Interim Results — ArriveNet : Press Releases
- Beazley Opens Singapore Office — Insurance Journal
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL
- Study to Be Published in JAMA: Diabetes Drug ACTOS(R) (pioglitazone HCl) Halted Progression of Key Marker for Atherosclerosis; Improvements Indicated by Carotid Intima-Media Thickness (CIMT)